A counterintuitive philosophy is gaining traction among healthcare strategists: building specialty drug networks that begin with a narrow, focused footprint rather than broad reach. That argument was put forward by three industry
Bayer’s Kerendia has secured a third FDA approval, becoming the first new therapeutic advance for chronic kidney disease linked to type 1 diabetes in more than three decades. The US regulator approved
More
Utah is cracking down on residents who exploit a well-known tax loophole by registering their vehicles in Montana to avoid paying sales tax and registration fees. The Montana loophole has long been
More
Kadant Inc. (KAI) is navigating a period of transition as investors assess the implications of a chief executive change at the industrial technology company. Leadership transitions at publicly traded companies often prompt
More
New research from the Chartered Management Institute reveals flexible working arrangements are among the leading reasons managers choose to remain with their current employers. The CMI surveyed over 1,000 managers and found
More
Cencora’s Ameer Ali is calling on pharmaceutical supply chain stakeholders to begin building their NDC-12 roadmaps without delay, warning that the transition requires significant preparation. Ali, speaking in the final installment of
More
California’s Office of Health Care Affordability has released revised emergency regulations implementing AB 1415, significantly expanding reporting requirements for private equity and healthcare investors. The September draft regulations retain many provisions from
More
Pets at Home (PETS) has endured a difficult stretch on the public markets, with its share price falling sharply by 59% from previous highs. The decline has placed the UK’s largest pet
More
Pharmaceutical supply chain compliance has long been viewed as a regulatory burden, but that perception is now shifting significantly across the industry. The Drug Supply Chain Security Act, known as DSCSA, set
More
The Court of Appeal has ruled that employers’ vicarious liability to third parties does not transfer to new employers under Transfer of Undertakings (Protection of Employment) legislation. The landmark judgment, handed down
More
Lisa Solbakken, co-founder and managing partner of Arkin Solbakken, has built a formidable reputation as a trusted adviser to elite legal professionals navigating high-stakes workplace exits. Known on Wall Street as a
More